Skip to main content
Premium Trial:

Request an Annual Quote

Mary Thistle

Enterome has appointed Mary Thistle to its board of directors as a non-executive director. Thistle currently serves as chief operating officer at Dimension Therapeutics, and has also served as senior VP of Business Development at Cubist Pharmaceuticals. Prior to joining Dimension in 2015, Thistle held leadership positions at ViaCell. In addition to developing therapeutic products for rare and metabolic liver diseases, Enterome also develops diagnostics to support therapies in microbiome-related diseases such as inflammatory bowel disease and cancer.